|
University of California - Los Angeles
Cause of ischemic stroke analyzed for the first time
Researchers study blockages retrieved by novel mechanical procedure
In contrast to traditional beliefs that stroke-causing clots derived from arterial and cardiac sources are distinctly different, a new UCLA study shows they are composed of
similar components.
Researchers studied clots removed from the brain blood vessels of 25 stroke victims. The clots were retrieved during treatment using a novel mechanical clot-retrieval device
called the MERCI (Mechanical Embolus Removal in Cerebral Ischemia) Retriever. The removed clots were analyzed under the microscope to compare their component structures.
"Unexpectedly, no two retrieved clots looked the same, even though all were constructed from the same basic components of fibrin, white cells and red blood cells,"
said lead author Dr. Victor Marder, professor of hematology and oncology at the David Geffen School of Medicine at UCLA and a UCLA Stroke Center member. "The same components were involved in both
the newly formed and mature, enlarging clots. Red blood-cell accumulations had previously been considered to dominate the structure of clots that formed within a heart chamber, but our results suggest
that red cells often accumulated on clots after impaction in the brain artery."
The findings could lead to better therapies to prevent clots, clear blockages and reverse strokes in the crucial first hours after they occur.
"This could potentially change the way we treat clots," said Dr. Jeffrey Saver, professor of neurology at the David Geffen School of Medicine at UCLA and
co-director of the UCLA Stroke Center. "Now that we can retrieve clots, we can analyze their molecular composition and determine the combination of mechanical therapies and clot-dissolving agents
most likely to allow us to open up arteries."
This study marks the first time that so many blockages, almost all of which were clots, have been analyzed in such detail.
"With the advent of the MERCI Retriever, we were finally able to systematically analyze blockages retrieved from live stroke victims within about six hours of symptom
onset," said Dr. Sidney Starkman, professor of emergency medicine and neurology at the David Geffen School of Medicine at UCLA and co-director of the UCLA Stroke Center. "In the past, clots
were studied from stroke victims who had died, and those clots were weeks, even months, old."
Ischemic stroke is the most common form of stroke and is the result of the blockage of a blood vessel feeding the brain. The blockages are typically clots that form in a
heart or a neck artery, break off and travel to a recipient artery in the brain. The area of the brain not able to get its blood supply is injured from the lack of blood flow. The brain-damaged region is
not able to do what it normally does, resulting in the signs and symptoms of stroke -- paralysis, difficulty speaking and difficulty seeing, among others.
The MERCI Retriever was invented at UCLA and sponsored by Concentric Medical of Mountain View, Calif. The Federal Drug Administration approved the MERCI Retriever in 2004
for removal of clots from brain arteries in patients experiencing ischemic stroke, within the first eight hours of stroke onset.
Adult stem cell research is far ahead of embryonic - Buffalo News Another heart-related condition under study is critical limb ischemia ... being studied for stem cell treatments: • Multiple sclerosis. In MS, the body’s immune system repeatedly assaults brain and spinal cord ...
Cardiac-Death Patient Kidneys Perform As Well As Those From Brain-Dead Patients - Medical News Today ... brain dead - individuals who had suffered brain-stem death, but whose hearts were still beating. Because treatments for head ... cardiac-death patient kidneys suffer warm ischemia between the heart stopping and ...
The Zacks Small-Cap Profile features Cytori Therapeutics, Aastrom Biosciences, StemCells and ... - PR Inside ... treatment of critical limb ischemia (CLI), an advanced form of peripheral artery disease (PAD), and dilated ... including the brain and liver of adult patients. StemCells also has a suite of specialty cell ...
Adult stem cell research far ahead of embryonic - Star-Tribune Another heart-related condition under study is critical limb ischemia, where ... being studied for stem cell treatments: --Multiple sclerosis. In MS, the body's immune system repeatedly assaults brain and spinal cord ...
Stem Cell Competition Heating Up - Seekingalpha.com ... critical limb ischemia ... treatments for amyotrophic lateral sclerosis [ALS], often referred to as “Lou Gehrig’s Disease.” ALS is a progressive neurodegenerative disease that affects nerve cells in the brain
New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments - Phramalive.com ... profiles of patients with neurological diseases who were observed from between one month to four years after treatment. No serious ... brain injury, cerebral palsy, lower limb ischemia, lupus, multiple sclerosis,
|
|